Form 4: Neurocrine Biosciences Executive Sells Shares
Insider Transaction (Form 4)
Ingrid Delaet, Chief Regulatory Officer of Neurocrine Biosciences Inc, sold 4,367 shares of common stock on July 10, 2026 for $181.02 per share.
Summary
- Option exercise/conversion: acquired 4,367 Common Stock at $106.02 ($462,989) on July 10, 2026; holds 20,592 after (Direct).
- Open-market sale: disposed of 4,367 Common Stock at $181.02 ($790,514) on July 10, 2026; holds 16,225 after (Direct).
- Option exercise/conversion: disposed of 4,367 Non-Qualified Stock Option on July 10, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $790,514 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Ingrid Delaet — Officer (Chief Regulatory Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-10 | Option exercise/conversion | Common Stock | 4,367 | $106 | $463.0K | 20,592 |
| 2026-07-10 | Open-market sale | Common Stock | 4,367 | $181 | $790.5K | 16,225 |
| 2026-07-10 | Option exercise/conversion | Non-Qualified Stock Option | 4,367 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-10 | Option exercise/conversion (4,367 shares) |
| 2026-07-10 | Open-market sale (4,367 shares) |
| 2026-07-10 | Option exercise/conversion (4,367 shares) |
Keywords
insider transaction, Form 4, NBIX, NEUROCRINE BIOSCIENCES INC, bearish, Ingrid Delaet
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.